Israel Englander’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,872
Closed -$482K 4568
2020
Q2
$482K Sell
2,872
-13,507
-82% -$2.12M ﹤0.01% 3428
2020
Q1
$2.15M Sell
16,379
-127,891
-89% -$18.2M ﹤0.01% 1969
2019
Q4
$21.5M Sell
144,270
-41,962
-23% -$5.76M 0.03% 795
2019
Q3
$23M Buy
+186,232
New +$24.8M 0.04% 689
2015
Q4
Sell
-2,123
Closed -$215K 3512
2015
Q3
$215K Sell
2,123
-1,159
-35% -$138K ﹤0.01% 3082
2015
Q2
$407K Sell
3,282
-3,024
-48% -$365K ﹤0.01% 2739
2015
Q1
$746K Buy
6,306
+140
+2% +$15.8K ﹤0.01% 2495
2014
Q4
$629K Buy
+6,166
New +$602K ﹤0.01% 2836

Other funds holding FBT

Israel Englander's FBT Position: Q3 2020 in Review

Israel Englander sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2020, closing a stake of 2,872 shares — an estimated $482K sold.

Israel Englander first reported a position in FBT in Q4 2014 and held it in 8 quarters. The position peaked at $23M in Q3 2019. 213 funds tracked by Wall St. Rank hold FBT as of Q3 2020.

  • Israel Englander reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2020 after selling out during the quarter.
  • Israel Englander sold 2,872 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2020, an estimated $482K.
  • Israel Englander first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and held it in 8 quarters.
  • Israel Englander's First Trust NYSE Arca Biotechnology Index Fund position peaked at $23M in Q3 2019.
  • 213 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.